
zzso are valuable zzso agents for prevention and therapy of zzso zzso However, as with other groups of zzso there are limitations to the use of zzso in zzso zzso they should not be used in those zzso patients receiving zzso or zzso for zzso because of the risk of infection with resistant zzso or less susceptible zzso zzso There are also insufficient data to support zzso of zzso zzso with zzso although some studies using higher zzso zzso have reported encouraging zzso More data on this issue, including use in zzso cancer patients, are zzso zzso are indicated for empirical therapy in combination with agents active against zzso organisms, such as broad spectrum zzso with or without zzso zzso or in combination with zzso or zzso Some studies have shown that a combination of zzso or zzso may provide better coverage against zzso but there are insufficient data on the combination of zzso with third generation zzso A specific group of patients with low risk mild to moderate zzso with solid zzso may benefit from oral therapy with zzso in combination with either an zzso with a zzso inhibitor or zzso After 10 years of zzso use in zzso zzso these agents can still be regarded as valuable drugs of choice; however, the zzso of resistance among zzso and zzso zzso especially in zzso using zzso as zzso is zzso 

